These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Effect of mitomycin-C on the variance in refractive outcomes after photorefractive keratectomy. Sy ME, Zhang L, Yeroushalmi A, Huang D, Hamilton DR. J Cataract Refract Surg; 2014 Dec; 40(12):1980-4. PubMed ID: 25305150 [Abstract] [Full Text] [Related]
17. Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Thornton I, Puri A, Xu M, Krueger RR. Am J Ophthalmol; 2007 Nov; 144(5):673-681. PubMed ID: 17889818 [Abstract] [Full Text] [Related]
18. The U.S. Army Surface Ablation Study: comparison of PRK, MMC-PRK, and LASEK in moderate to high myopia. Sia RK, Ryan DS, Edwards JD, Stutzman RD, Bower KS. J Refract Surg; 2014 Apr; 30(4):256-64. PubMed ID: 24702577 [Abstract] [Full Text] [Related]
19. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical study. Hashemi H, Taheri SM, Fotouhi A, Kheiltash A. BMC Ophthalmol; 2004 Sep 14; 4():12. PubMed ID: 15363107 [Abstract] [Full Text] [Related]
20. Corneal haze among blue eyes and brown eyes after photorefractive keratectomy. Tabbara KF, El-Sheikh HF, Sharara NA, Aabed B. Ophthalmology; 1999 Nov 14; 106(11):2210-5. PubMed ID: 10571361 [Abstract] [Full Text] [Related] Page: [Next] [New Search]